|This document is available in two formats: this web page (for browsing content) and PDF (comparable to original document formatting). To view the PDF you will need Acrobat Reader, which may be downloaded from the Adobe site. For an official signed copy, please contact the Antitrust Documents Group.|
IN THE UNITED STATES DISTRICT COURT
The United States of America, acting through its attorneys, charges:I
DESCRIPTION OF THE OFFENSE
1. Degussa-Hüls AG, a corporation organized and existing under the laws of Germany, is made a defendant on the charge stated below.
2. Beginning at least as early as January 1992 and continuing until at least March 1998, the exact dates being unknown to the United States, the defendant and co-conspirators entered into and participated in a combination and conspiracy to suppress and eliminate competition by fixing the price and allocating the volume of niacin and niacinamide sold in the United States and elsewhere. The combination and conspiracy engaged in by the defendant and co-conspirators was in unreasonable restraint of interstate and foreign trade and commerce in violation of Section 1 of the Sherman Act (15 U.S.C. § 1).
3. The charged combination and conspiracy consisted of a continuing agreement, understanding, and concert of action among the defendant and co-conspirators, the substantial terms of which were:
4. For the purpose of forming and carrying out the charged combination and conspiracy, the defendant and co-conspirators did those things that they combined and conspired to do, including, among other things:
5. Niacin and niacinamide are vitamins of the B-complex group. These vitamins are sold by manufacturers and resellers to customers in both the human and animal nutrition industries. Niacin and niacinamide are ingredients necessary for the growth and development of both humans and animals.III
DEFENDANT AND CO-CONSPIRATORS
6. During the period covered by this Information, Degussa AG, the predecessor corporation of Degussa-Hüls AG, was a corporation organized and existing under the laws of Germany. Degussa AG was a manufacturer of niacin and niacinamide and was engaged in the sale of niacin and niacinamide throughout the United States and in foreign countries. On February 1, 1999, Degussa AG merged with Hüls AG, forming Degussa-Hüls AG. Degussa-Hüls AG has its principal place of business in Frankfurt am Main, Germany.
7. Various corporations and individuals not made defendants herein participated as co-conspirators in the offense charged herein and performed acts and made statements in furtherance thereof.
8. Wherever in this Information reference is made to any act, deed, or transaction of a corporation, the allegation means that the corporation engaged in the act, deed, or transaction by or through its officers, directors, agents, employees, or representatives while they were actively engaged in the management, direction, control, or transaction of its business or affairs.
TRADE AND COMMERCE
9. During the period covered by this Information, the defendant and co-conspirators sold and distributed a substantial quantity of niacin and niacinamide in a continuous and uninterrupted flow of interstate and foreign trade and commerce to customers located in states or countries other than the states or countries in which the niacin and niacinamide were produced.
10. During the period covered by this Information, the activities of the defendant and co-conspirators thatare the subject of this Information were within the flow of, and substantially affected, interstate and foreign trade and commerce.V
JURISDICTION AND VENUE
11. The combination and conspiracy charged in this Information was carried out, in part, within the Northern District of Texas within the five years preceding the filing of this Information.
ALL IN VIOLATION OF TITLE 15, UNITED STATES CODE, SECTION 1.